Cagrilintide 5mg

Cagrilintide is a long-acting amylin analogue developed as a modified version of the endogenous pancreatic hormone amylin, engineered for extended half-life. It has been studied for its activity at amylin and calcitonin receptor complexes, which mediate amylin’s physiological role in gastric emptying and satiety signalling.

Research interest has centred on the compound’s receptor selectivity profile and its behaviour in combination with incretin-pathway agents in metabolic studies. Third-party lab tested and supplied for research and development use only.

Product specifications

• Compound: CAGRILINTIDE
• Quantity: 5 MG
• Purity: ≥98.0%
• Supplier: House of Nutrition
• Use: Research and development only

Certificate of Analysis: View COA

Research-use notice: This product is intended for research and development use only and is not for human consumption.